Michael Sassano

Cautiously optimistic is one way to look at former President Donald Trump’s electoral win among cannabis industry leaders, some of whom say they are balancing hope for reforms with concerns over regulatory clarity and state autonomy. As the industry awaits Trump's direction on cannabis...

SOMAÍ Pharmaceuticals has partnered with Georgelle Pharmaceutical Ltd. to bring an extensive range of cannabis-based medicines to Irish patients. This marks SOMAÍ's fifth international expansion, having already established operations in the UK, Australia, Germany, and Poland earlier this year....

SOMAÍ Pharmaceuticals, a Portugal-headquartered marijuana company has partnered with Cosma S.A., a Poland-based company focused on cannabis-based pharmaceutical advancements. Under this strategic partnership, Cosma is designated as the marketing authorization holder (MAH) for both Cosma and SOMAÍ's...

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s...

Over the last few years, medical marijuana has experienced significant breakthroughs across Europe as many countries recognize its benefits with several countries having decriminalized the possession of small amounts. Some three years ago, the European Court ruled against...

European pharmaceutical cannabis product manufacturer SOMAÍ Pharmaceuticals Unipessoal LDA received authorization for its facility in Lisbon, Portugal, from the Portuguese Health Authority INFRAMED. Why It Matters This authorization allows the company to produce, import, and export medicinal...

SOMAÍ Pharmaceuticals Unipessoal LDA has entered into a two-year supply agreement with a Polish distributor Cosma Cannabis. Cosma produces medical-grade cannabis products for importation and distribution across Poland. The contract represents 1 million euros ($1.08 million) in sales for SOMA...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. With the first shipments under the agreement already completed, Clever Leaves...

SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1 manufacturing footprint spans 3,800 square meters of manufacturing floor, independent laboratory and offices. To date, the facility has already...

By Michael Sassano, founder and CEO of Solaris Farms, one of the largest and most high tech cannabis growers in Nevada, and Head of the Board at Somai Pharma, a medical cannabis product distributor in the European Union. Don’t panic, but it’s time to look at a slow down in all...